COVID-19 and Diabetes: What You Need to Know
What is the impact of COVID-19 on adult patients with type 2 diabetes (T2D) and how do we navigate healthcare when an epidemic and pandemic seemingly join forces to further exacerbate patient outcomes? Join experts in T2D: Dr. John Anderson (primary care provider), Dr. Eden Miller (primary care provider), and Dr. Serge Jabbour (endocrinologist) for an in-depth discussion on how COVID-19 impacts patients with T2D and what you can do to help your patients as new information is discovered during this evolving landscape.
This podcast is sponsored by Novo Nordisk and is intended for clinicians. The opinions expressed are those of the speakers and not Novo Nordisk.
John E. Anderson, MD, is an internal medicine physician and diabetes specialist at The Frist Clinic in Nashville, Tennessee.
Eden Miller, DO, FOMA, is a diabetes care, obesity, and family medicine provider and the founder of Diabetes and Obesity Care, LLC, in Bend, Oregon.
Serge A. Jabbour, MD, FACP, FACE, is a professor of medicine in the Division of Endocrinology, Diabetes, and Metabolic Diseases and director of the Jefferson Diabetes Center at the Sidney Kimmel Medical College/Thomas Jefferson University in Philadelphia, Pennsylvania.